A circular split nanoluciferase reporter for validating and screening putative internal ribosomal entry site elements
RNA · 2024
DOI: 10.1261/rna.080008.124 ↗Kurz gefasst
Fachartikel in der Zeitschrift RNA, 2024. Verfasst von Mildred J Unti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Weill Cornell Medicine, Cornell University, New York, New York 10065, USA. Hauptthemen laut MEDLINE: Internal Ribosome Entry Sites, Genes, Reporter, RNA, Circular, Luciferases. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NHGRI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Internal ribosomal entry sites (IRESs) recruit the ribosome to promote translation, typically in an m7G cap-independent manner. Although IRESs are well-documented in viral genomes, they have also been reported in mammalian transcriptomes, where they have been proposed to mediate cap-independent translation of mRNAs. However, subsequent studies have challenged the idea of these “cellular” IRESs. Current methods for screening and discovering IRES activity rely on a bicistronic reporter assay, which is prone to producing false positive signals if the putative IRES sequence has a cryptic promoter or cryptic splicing sites. Here, we report an assay for screening IRES activity using a genetically encoded circular RNA comprising a split nanoluciferase (nLuc) reporter. The circular split nLuc reporter is less susceptible to the various sources of false positives that adversely affect the bicistronic IRES reporter assay and provides a streamlined method for screening IRES activity. Using the circular split nLuc reporter, we find that nine reported cellular IRESs have minimal IRES activity. Overall, the circular split nLuc reporter offers a simplified approach for identifying and validating IRESs and exhibits reduced propensity for producing the types of false positives that can occur with the bicistronic reporter assay.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Weill Cornell Medicine, Cornell University, New York, New York 10065, USA.
- Imperial College Centre for Synthetic Biology, Imperial College London, London SW7 2AZ, United Kingdom.
- Department of Bioengineering, Imperial College London, London SW7 2AZ, United Kingdom.
- Department of Pharmacology, Weill Cornell Medicine, Cornell University, New York, New York 10065, USA srj2003@med.cornell.edu.
ORCID-Profile: Mildred J Unti
Förderung
- NINDS NIH HHS
- NHGRI NIH HHS
- NIH HHS
- NIGMS NIH HHS
- NIH
- Moderna Global Fellowship
Zitieren
APA
Unti, M. J., Doetsch, L., & Jaffrey, S. R. (2024). A circular split nanoluciferase reporter for validating and screening putative internal ribosomal entry site elements. RNA. https://doi.org/10.1261/rna.080008.124
Vancouver
Unti MJ, Doetsch L, Jaffrey SR. A circular split nanoluciferase reporter for validating and screening putative internal ribosomal entry site elements. RNA. 2024. doi:10.1261/rna.080008.124
BibTeX
@article{Unti2024,
author = {Unti, Mildred J and Doetsch, Lisa and Jaffrey, Samie R},
title = {A circular split nanoluciferase reporter for validating and screening putative internal ribosomal entry site elements},
journal = {RNA},
year = {2024},
doi = {10.1261/rna.080008.124}
}
EUVIMED